Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis from a Single High-volume Center in Asia

Annals of Surgery

Volumn 265, Issue 5, 2017, Pages 946-953

  Chon, Hong Jae ^a,b   Hyung, Woo Jin ^b   Kim, Chan ^a   Park, Sohee ^c   Kim, Jie Hyun ^d   Park, Chan Hyuk ^e   Ahn, Joong Bae ^f   Kim, Hyunki ^b   Chung, Hyun Cheol ^f   Rha, Sun Young ^f   Noh, Sung Hoon ^b   Jeung, Hei Cheul ^d  

^a CHA University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Hanyang University Guri Hospital   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

Author keywords

gastric cancer; prognostic factor; signet ring cell carcinoma

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADICAL RESECTION; RETROSPECTIVE STUDY; SIGNET RING CARCINOMA; STOMACH CARCINOMA; ADENOCARCINOMA; AGED; ASIA; CARCINOMA, SIGNET RING CELL; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; HIGH VOLUME HOSPITAL; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SOUTH KOREA; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR INVASION; TUMOR RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; ASIA; BIOPSY, NEEDLE; CARCINOMA, SIGNET RING CELL; CAUSE OF DEATH; COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HOSPITALS, HIGH-VOLUME; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84970002304     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001793     Document Type: Article

References (18)

1. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. World Health Organization; 2010.
2. Lauren P. The two histological main types of gastric carcinoma, an attempt at a histoclinical classification. Acta Pathol Microbiol Scand. 1965;64:31-49.
3. Ribeiro MM, Sarmento JA, Simoes M, et al. Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma. Cancer. 1981;47:780-784.
4. Piessen G, Messager M, Leteurtre E, et al. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg. 2009;250:878-887.
5. Hyung WJ, Noh SH, Lee JH, et al. Early gastric carcinoma with signet ring cell histology. Cancer. 2002;94:78-83.
6. Kunisaki C, Shimada H, Nomura M, et al. Therapeutic strategy for signet ring cell carcinoma of the stomach. Brit J Surg. 2004;91:1319-1324.
7. Taghavi S, Jayarajan SN, Davey A, et al. Prognostic significance of signet ring gastric cancer. J Clinic Oncol. 2012;30:3493-3498.
8. Bamboat ZM, Tang LH, Vinuela E, et al. Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma. Ann Surg Oncol. 2014;21:1678-1685.
9. Choi Y, Gwack J, Kim Y, et al. Long term trends and the future gastric cancer mortality in Korea: 1983-2013. Breast Cancer Res Treat. 2006;38:7.
10. Shah MA, Khanin R, Tang L, et al. Molecular classification of gastric cancer: a new paradigm. Clinical Cancer Res. 2011;17:2693-2701.
11. Lei Z, Tan IB, Das K, et al. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology. 2013;145:554-565.
12. Chon HJ, Kim HR, Shin E, et al. The clinicopathologic features and prognostic impact of ALK positivity in patients with resected gastric cancer. Ann Surg Oncol. 2015;22:3938-3945.
13. Humar B, Guilford P. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci. 2009;100:1151-1157.
14. Blair V, Martin I, Shaw D, et al. Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol. 2006;4:262-275.
15. Lee Y-S, Cho YS, Lee GK, et al. Genomic profile analysis of diffuse-type gastric cancers. Genome Biol. 2014;15:R55.
16. Wang K, Yuen ST, Xu J, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nature Genet. 2014;46:573-582.
17. Kim DY, Park YK, Joo JK, et al. Clinicopathological characteristics of signet ring cell carcinoma of the stomach. ANZ J Surg. 2004;74:1060-1064.
18. Kwon K-J, Shim K-N, Song E-M, et al. Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach. Gastric Cancer. 2014;17:43-53.